2011 saw lower than expected performance of allergy eye care products in Ireland. Due to poor summer weather, products aimed at seasonal allergies such as hayfever did not perform as well as expected by manufacturers as people spent less time outdoors and pollen levels remained lower than usual. This situation improved slightly towards the end of the summer season, especially during August and September when weather conditions improved. This was unusual for Ireland where the hayfever season...
Euromonitor International's Eye Care in Ireland report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.
Product coverage: Allergy Eye Care, Standard Eye Care.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
Euromonitor International's Eye Care in Ireland report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.
Product coverage: Allergy Eye Care, Standard Eye Care.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Eye Care market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Eye Care by Category: Value 2006-2011
Table 2 Sales of Eye Care by Category: % Value Growth 2006-2011
Table 3 Standard Eye Care by Format: % Value Breakdown 2007-2011
Table 4 Standard Eye Care by Positioning: % Value Breakdown 2007-2011
Table 5 Eye Care Company Shares by Value 2007-2011
Table 6 Eye Care Brand Shares by Value 2008-2011
Table 7 Forecast Sales of Eye Care by Category: Value 2011-2016
Table 8 Forecast Sales of Eye Care by Category: % Value Growth 2011-2016
Executive Summary
Consumer Health Remains Positive
New Guidance for OTC Paediatric Cough/cold Remedies for Children Under Six
Government Cuts Encourage OTC Sales
Pharmacy-led Sales Dominate Channels
Forecast Performance Expected To Be Muted
Key Trends and Development
Difficult Economic Conditions Persist
Your Health Is Your Wealth
Cost Cutting May Lead To Increased Switching
Value Remains Key for Consumers
Market Indicators
Table 9 Consumer Expenditure on Health Goods and Medical Services 2006-2011
Table 10 Life Expectancy at Birth 2006-2011
Market Data
Table 11 Sales of Consumer Health by Category: Value 2006-2011
Table 12 Sales of Consumer Health by Category: % Value Growth 2006-2011
Table 13 Consumer Health Company Shares 2007-2011
Table 14 Consumer Health Brand Shares 2008-2011
Table 15 Penetration of Private Label by Category 2006-2011
Table 16 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
Table 17 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
Table 18 Forecast Sales of Consumer Health by Category: Value 2011-2016
Table 19 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
Prescription-only Classification
Controlled Drugs
OTC Consumer Health Products
Restrictions on the Sale of Acetaminophen Products
Restrictions on the Sale of Codeine Products
De-listing and De-reimbursement
Switching and Reimbursable Status
Advertising
Manufacturers Seek Greater Freedom in Advertising Prescription-only Products
Self-regulation
Packaging and Labelling
Distribution
Distance Selling Remains Prohibited, While Imports for Personal Use Remain Legal
Vitamins and Dietary Supplements Registration and Classification
Restrictions on the Sale of Products Containing Vitamin Or Mineral Ingredients
EU Legislation
Self-medication/self-care and Preventative Medicine
Generics
Switches
Summary 1 OTC - Switches 2009-2011
Sources
Summary 2 Research Sources
Trends
Switches
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Eye Care by Category: Value 2006-2011
Table 2 Sales of Eye Care by Category: % Value Growth 2006-2011
Table 3 Standard Eye Care by Format: % Value Breakdown 2007-2011
Table 4 Standard Eye Care by Positioning: % Value Breakdown 2007-2011
Table 5 Eye Care Company Shares by Value 2007-2011
Table 6 Eye Care Brand Shares by Value 2008-2011
Table 7 Forecast Sales of Eye Care by Category: Value 2011-2016
Table 8 Forecast Sales of Eye Care by Category: % Value Growth 2011-2016
Executive Summary
Consumer Health Remains Positive
New Guidance for OTC Paediatric Cough/cold Remedies for Children Under Six
Government Cuts Encourage OTC Sales
Pharmacy-led Sales Dominate Channels
Forecast Performance Expected To Be Muted
Key Trends and Development
Difficult Economic Conditions Persist
Your Health Is Your Wealth
Cost Cutting May Lead To Increased Switching
Value Remains Key for Consumers
Market Indicators
Table 9 Consumer Expenditure on Health Goods and Medical Services 2006-2011
Table 10 Life Expectancy at Birth 2006-2011
Market Data
Table 11 Sales of Consumer Health by Category: Value 2006-2011
Table 12 Sales of Consumer Health by Category: % Value Growth 2006-2011
Table 13 Consumer Health Company Shares 2007-2011
Table 14 Consumer Health Brand Shares 2008-2011
Table 15 Penetration of Private Label by Category 2006-2011
Table 16 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
Table 17 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
Table 18 Forecast Sales of Consumer Health by Category: Value 2011-2016
Table 19 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
Prescription-only Classification
Controlled Drugs
OTC Consumer Health Products
Restrictions on the Sale of Acetaminophen Products
Restrictions on the Sale of Codeine Products
De-listing and De-reimbursement
Switching and Reimbursable Status
Advertising
Manufacturers Seek Greater Freedom in Advertising Prescription-only Products
Self-regulation
Packaging and Labelling
Distribution
Distance Selling Remains Prohibited, While Imports for Personal Use Remain Legal
Vitamins and Dietary Supplements Registration and Classification
Restrictions on the Sale of Products Containing Vitamin Or Mineral Ingredients
EU Legislation
Self-medication/self-care and Preventative Medicine
Generics
Switches
Summary 1 OTC - Switches 2009-2011
Sources
Summary 2 Research Sources